Document:

Filtering Exhibit

    
      

      

    

    Exhibit
      10.1

     

     

    
      FIRST
        AMENDMENT TO

      AGREEMENT
        AND PLAN OF MERGER

       

      THIS
        FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (the “Amendment”) is entered
        into as of December 18, 2006, by and among FILTERING ASSOCIATES, INC., (“FAI”),
        a Nevada corporation, and Kevin Frost and Edward Wiggins, individual
        stockholders of FAI (the “FAI Stockholders”), on the one hand, and MATINEE MEDIA
        CORPORATION, a Texas corporation (the “Company”), on the other
        hand.

       

      BACKGROUND

       

      A.     FAI,
        the
        FAI Stockholders and the Company entered into an Agreement and Plan of Merger
        (the “Agreement”) on April 13, 2006. All capitalized terms used herein have the
        same meanings given to them in the Agreement.

       

      B.     On
        October 5, 2006, the Company executed a non-binding letter of intent with
        US
        Farm & Ranch Supply Company, Inc. (d/b/a USFR Media Group) (“USFR”),
        regarding a merger of USFR with and into the Company (the “USFR
        Merger”).

       

      C.     On
        November 10, 2006, USFR borrowed $28.0 million for the purchase of KTBU
        Television, Conroe, Texas and, in connection with that loan, the Company
        executed a security agreement for the benefit of the USFR lenders, pursuant
        to
        which the Company pledged all of its interests in the option agreements under
        which the Company has the exclusive right to purchase 24 FM radio permits,
        subject to prior FCC approval (the “USFR Pledge”).

       

      D.     The
        Company and USFR have executed, or expect to execute, an agreement and plan
        of
        merger (the “USFR Merger Agreement”), pursuant to which, upon the closing of the
        USFR Merger, the shareholders of USFR (including the holders of options,
        warrants or convertible securities of USFR) will receive shares of Company
        Stock
        (or options, warrants or convertible securities of the Company with terms
        similar to those of the securities of USFR held by such holders) representing
        55% of the shares of Company Stock that will be outstanding, on a fully diluted
        basis (including shares of FAI to be outstanding immediately prior to the
        Effective Time of the Merger). The Company expects that the USFR Merger will
        be
        consummated prior to the Effective Time of the Merger.

       

      E.     Each
        of
        FAI, the FAI Stockholders and the Company desires to amend the Agreement
        by
        entering into this Amendment.

       

      NOW,
        THEREFORE, for good and valuable consideration, the receipt and sufficiency
        of
        which are hereby acknowledged, the parties hereby agree as follows:

       

      1.     Section
        1.08 of the Agreement is hereby amended to read in its entirety as
        follows:

       

      “1.08 Stock
        Cancellation. On
        or
        before
        the Closing, FAI shall cause to be cancelled 1,662,214 shares of its outstanding
        Common Stock held by certain of its stockholders who hold restricted Common
        Stock and it shall transfer to such stockholders its existing business and
        related assets and liabilities in consideration of the cancellation of their
        FAI
        Common Stock. After the cancellation of these shares, the total outstanding
        shares of FAI as of immediately prior to the Effective Time of the Merger
        shall
        not exceed 1,210,786 shares of Common Stock.”

       

      
        
          
          

        

        
          1

          
            

          

        

        
          
          

        

      

       

      2.     Section
        2.03(a) of the Agreement is hereby amended to read in its entirety as
        follows:

       

      “(a)   Assumption
        of Company Derivatives.
        At the
        Effective Time of the Merger, each outstanding warrant or option to purchase
        Company Stock (each a “Company Warrant”) shall by virtue of the Merger be
        assumed by Public FAI and each employee stock incentive plan of the Company
        under which any Company Warrant may be granted (the “Company Plans”) shall by
        virtue of the Merger be assumed by Public FAI, and each outstanding promissory
        note convertible into Company Stock (each a “Company Convertible Note”) shall by
        virtue of the Merger be assumed by Public FAI. Each Company Warrant and Company
        Convertible Note so assumed by Public FAI will (i) continue to have, and
        be
        subject to, the same terms and conditions of such Company Warrant or Company
        Convertible Note immediately prior to the Effective Time of the Merger and
        will
        be exercisable for or convertible into a number of shares of Public FAI Common
        Stock equal the number of shares of Company Stock that were issuable upon
        exercise of such Company Warrant or conversion of such Company Convertible
        Note
        immediately prior to the Effective Time of the Merger, (ii) the total
        exercise price for the shares of Public FAI Common Stock issuable upon exercise
        of each such assumed Company Warrant will be equal to the total exercise
        price
        that would have been paid prior to the Effective Time of the Merger if such
        Company Warrant were exercised in full prior to the Effective Time of the
        Merger, and (iii) the conversion price for the shares of Public FAI Common
        Stock
        issuable upon conversion of each such assumed Company Convertible Notes will
        be
        equal to the conversion price that would have been applicable prior to the
        Effective Time of the Merger if such Company Convertible Note were converted
        in
        full prior to the Effective Time of the Merger. Public FAI shall comply with
        the
        terms of all such Company Warrants, Company Convertible Notes and Company
        Plans.
        Public FAI shall take all corporate actions necessary to reserve for issuance
        a
        sufficient number of shares of Public FAI Common Stock for delivery upon
        exercise of all Company Warrants and conversion of all Company Convertible
        Notes
        outstanding at the Effective Time of the Merger on the terms set forth in
        this
        Section 2.03 and all other shares of Public FAI Common Stock issuable under
        the Company Plans.”

       

      3.     Section
        2.03(c) of the Agreement is hereby amended to read in its entirety as
        follows:

       

      “(c)   Adjustment
        to Exchange Ratios.
        The FAI
        Exchange Ratio and the Company Exchange Ratio set forth above in Section
        2.01(b)
        are based on the assumption that the shareholders of FAI will own 8% of the
        outstanding Common Stock of Public FAI as of immediately after the Effective
        Time of the Merger, without taking into consideration the shares of Company
        Stock that may be issued in the USFR Merger. If necessary to maintain this
        percentage ownership immediately after the Effective Time of the Merger,
        the
        Company Exchange Ratio set forth in Section 2.01(b) or the FAI Exchange Ratio
        set forth in Section 2.01(a) shall be proportionately adjusted so as to achieve
        this 8% target for the FAI shareholders in the Merger.”

       

      
        
          
          

        

        
          2

          
            

          

        

        
          
          

        

      

       

      4.    The
        first
        sentence of Section 3.01(c) of the Agreement is hereby amended to read in
        its
        entirety as follows:

       

      “The
        authorized capital stock of the Company consists of 25,000,000 shares of
        Company
        Stock, of which 13,924,041 shares are issued and outstanding, including the
        securities issued in the Company Funding, as described in Schedule 3.01(c)
        of
        the Company Disclosure Schedule.”

       

      5.     Section
        6.03(g) of the Agreement is hereby amended to read in its entirety as
        follows:

       

      “(g)   Cancellation
        of Stock.
        At
        Closing, FAI shall have cancelled 1,662,214 shares of its outstanding restricted
        common stock from the FAI Stockholders as provided in Section 1.08 and provide
        evidence of cancellation of those shares satisfactory to counsel for the
        Company.”

       

      6.     Section
        7.01(c) of the Agreement is hereby amended to read in its entirety as
        follows:

       

      “(c)    by
        either
        FAI or the Company, so long as such party is not in breach hereunder, if
        the
        Merger shall not have been consummated on or before June 1, 2007 (other than
        as
        a result of the failure of the party seeking to terminate this Agreement
        to
        perform its obligations under this Agreement required to be performed at,
        or
        prior to, the Effective Time of the Merger, in which event such party may
        not
        terminate this Agreement pursuant to this provision for a period of ten days
        following such party’s cure of such failure); provided,
        however,
        that if
        either FAI or Company requests an extension of the Closing after this date
        and
        the other party consents in writing, then neither party may terminate this
        Agreement under this provision until the expiration of such extension
        period;”

       

      7.    FAI
        and
        the FAI Stockholders acknowledge that the Company has entered into an agreement
        and plan of merger with USFR pursuant to which, prior to the Effective Time
        of
        the Merger, the Company may issue to the securityholders of USFR, upon the
        consummation of the USFR Merger, shares of Company Stock, Company Warrants
        and
        Company Convertible Notes. FAI and the FAI Stockholders hereby agree, approve
        and consent to the USFR Pledge, the execution of the USFR Merger Agreement
        and
        the consummation of the USFR Merger prior to the Effective Time of the Merger,
        and acknowledge that the consummation of the USFR Merger will not result
        in an
        adjustment to the FAI Exchange Ratio, except as set forth in this
        Amendment.

       

      8.    For
        purposes of Section 6.02 of the Agreement, prior to the Closing Date, the
        Company will deliver to FAI and the FAI Stockholders an updated Company
        Disclosure Schedule reflecting, among other things, the effects of the USFR
        Merger, if consummated prior to the Closing Date.

       

      9.    Except
        as
        and to the extent expressly amended by this Amendment, the Agreement remains
        in
        full force and effect in accordance with its terms.

       

      10.   This
        Amendment may be executed by the parties hereto in separate counterparts,
        each
        of which when so executed and delivered will be an original, but all such
        counterparts will together constitute one and the same instrument.

       

      
        
          
          

        

        
          3

          
            

          

        

        
          
          

        

         

      

      IN
        WITNESS WHEREOF, the undersigned have caused their duly authorized officers
        to
        execute this Amendment as of the date first above written.

       

      
        	
                FAI
                  STOCKHOLDERS:

              	 	 	
                FILTERING
                  ASSOCIATES, INC.

              
	 	 	 	 
	/s/ Kevin
                Frost	 	 	/s/ David
                Choi
	
                

                Kevin
                  Frost

              	 	 	
                
Name:
                David Choi
Its:
                President

      

      
        	 	 	 	
                 

              
	 	 	 	 
	/s/ Edward
                Wiggins	 	 	 
	
                
Edward
                Wiggins	 	 	
              

        	 	 	 	
                MATINEE
                  MEDIA CORPORATION

              
	 	 	 	 
	 	 	 	/s/ Robert
                Walker
	
              	 	 	
                
Name:
                Robert Walker
Its:
                President

      

       

      4Exhibit 4(c)(1)

                                                          All Correspondence to:
     PROGEN
INDUSTRIES LIMITED                                           PO Box 2403 Toowong
                                                       Queensland 4066 Australia
                                                      Telephone: +61 7 3842 3333
                                                      Facsimile: +61 7 3720 9624
                                                               www.progen.com.au

April 7, 2006

T. Justus Homburg
33 Anchorage Street
Cleveland Qld 4163

Dear Justus,

The company is pleased to offer you the position of CEO/Managing Director on the
terms contained in this agreement. This contract supersedes your previous
contract dated November 1, 2005.

We are confident that you will have a challenging and rewarding association with
us. Should you wish to discuss any of the terms of your employment, please
contact me.

1.   ENGAGEMENT

     Your employment with the company (Progen) will be in the position set out
     in section 14 (Schedule 2) from the commencement date set out in Section 13
     (Schedule 1), subject to termination in accordance with section 8.

1.1  The company will employ you on a full-time basis. The nature of your work
     means that your employment will he based at the workplaces set out in
     schedule 1 ('your workplace').

1.2  Your normal working hours are set out in Schedule 1, but in order to meet
     the demands of your position you will be required to work as can be
     reasonably expected of someone assuming the position. This will include
     travelling and working outside normal hours to undertake and accomplish
     your duties pursuant to this agreement.

1.3  Overtime will be paid in accordance with any applicable award. In the
     absence of an applicable award, any overtime worked will not be paid for.

2.   YOUR DUTIES

2.1  The principal duties of your position are set out in Schedule 2 to this
     agreement and may include other duties outside this scope as advised by the
     company from time to time ('your duties') but within the scope of
     performance expected of this position in the Biotech industry.

Corporate Offices and                       Drug Discovery and Biopharmaceutical
Clinical Development                        Manufacturing Facility
16 Benson Street                            2806 Ipswich Road
Toowong QLD 4066                            Darra QLD 4076

<PAGE>
                                     -2-

2.2  While employed by the company, you will not, without the company's written
                                                                        -------
     permission:

     (a)  perform your duties other than for the company or on its behalf; or

     (b)  engage in any other employment, business or profession.

2.3  You warrant that you have the expertise, qualifications, licences and
     registration necessary to perform your duties and will perform them in a
     manner appropriate to a person having such expertise, qualifications,
     licences or registration. You must maintain that expertise, qualifications,
     licences and registration and the company will reimburse your for
     reasonable costs associated with this maintenance on a case-by-case and
     needs basis.

2.4  You will at all times act in the best interests of, well and faithfully
     serve and promote the company's business and interests.

2.5  Subject to your remuneration as described in Schedule 1, or any other
     benefit you maybe paid by the company, by way of bonus or reimbursement,
     you will not accept any payment or any other benefit from any person as an
     inducement or reward for any act or forbearance in connection with any
     matter or business transacted by the company, on the company's behalf or on
     behalf of an Associated Business or Client.

3.   REMUNERATION AND LEAVE ENTITLEMENTS

3.1  You will be provided with the remuneration and leave entitlements set out
     in Schedule 1.

3.2  You authorise the company to deduct from your remuneration and leave
     entitlements any amount attributable to unauthorised absences or approved
     unpaid leave.

3.3  The superannuation fund into which contributions on your behalf will be
     paid is set out in Schedule 1, Your superannuation will be calculated on
     the basis of the rate prescribed in the superannuation guarantee
     legislation from time to time (currently 9%), calculated on your salary.

3.4  Prior to departing on annual leave you are to ensure that:

     (a)  all work for which you are responsible has been delegated to
          other suitably qualified employees for the period of your absence; and

     (b)  where possible your contact details during the period of your
          absence have been provided to your supervisor/manager so that you can
          be contacted if necessary.

3.5  On provision of receipts or other documentary evidence to the company's
     satisfaction, you will be reimbursed for reasonable work-related expenses
     properly incurred by you in the performance of your duties. The company
     will meet your accommodation, attendance and travelling costs whenever is
     necessary for you to travel or stay away from your residence in the
     performance of your duties. Please refer the Progen Employee Manual Version
     2.0 for further details.

3.6  Your remuneration and entitlements set out IN this letter of appointment
     are the only entitlements you are entitled to and you will receive no other
     benefits regardless of the number of hours, the days on which or the
     conditions in which you work.

4.   PERFORMANCE REVIEWS

4.1  Your work performance and conduct will be reviewed by the company and
     discussed with you from time to time. You acknowledge that the performance
     reviews are not necessarily linked to your salary increases.

<PAGE>
                                     -3-

4.2  You should raise any query or concern regarding your employment as soon as
     a query or concern arises, and not await the performance review.

5.   DUTY OF CONFIDENTIALITY

5.1  You will not at any time, whether or not employed by the company, use or
     disclose any Confidential Information, without the company's prior
     permission, unless:

     (a)  it is strictly necessary for you to perform your duties; or

     (b)  for the purpose of disclosure only, you are legally obliged to
          disclose by a court, commission or tribunal.

5.2  You will not, and will not permit anybody else to, without our prior
     permission seek to obtain Confidential Information to which you have not
     been granted access, nor will you;

     (a)  remove any Confidential Information from the company's or any
          Associated Business' or Clients' premises;

     (b)  make any copies of Confidential Information; or

     (c)  bring any computer software, tapes or disks onto the company's or
          an Associated Business' or Clients' premises other than for the
          purposes of carrying out your duties;

     unless it is for the purposes of satisfying sections 5.l(a) and 5.1(b).

5.3  When Confidential Information is disclosed in accordance with paragraph
     5.1, you will ensure that the person to whom the information is disclosed
     is made aware of its confidential nature and do everything in your power to
     ensure that person does not use or disclose that information.

5.4  You acknowledge that if confidential information is released to the market
     it may affect the price of Progen's securities, which are quoted on the
     Australia Stock Exchange and NASDAQ. You undertake not to engage in trading
     in Progen's securities, which may give rise to a breach by you or Progen of
     any law in Australia, USA or elsewhere relating to insider trading or
     unlawful conduct in relation to dealings in securities,

5.5  'CONFIDENTIAL INFORMATION' means all information belonging to us or an
     Associated Business, and includes information which:

     (a)  the company or an Associated Business or a Client indicates is
          confidential;

     (b)  by its very nature, might reasonably be understood to be
          confidential or to have been disclosed in confidence;

     (c)  would be of commercial value to ft competitor of the company or
          an Associated Business or Client;

     (d)  relates to the company's or an Associated Business' or Clients'
          financial or business affairs (including financial information,
          accounts work, financing information, management reports and
          performance or profitability reports and margins);

     (e)  relates to any of the company's or an Associated Business'
          clients (including but not limited to client details, client lists,
          details of client requirements, details of prospective clients, the
          identity or contact details of any client, their requirements and
          their financial affairs and details of our clients' dealings or
          financial arrangements with other parties);

<PAGE>
                                     -4-

     (f)  relates to any arrangements or transactions between the company
          or an Associated Business and a Client (including the prices charged
          to clients and details of the arrangements or transactions);

     (g)  relates to or is contained in any manuals or handbooks produced
          by the company or an Associated Business or Client;

     (h)  relates to the company's or an Associated Business' or Clients'
          fees, quotations, prices or charges in respect of services or
          products;

     (i)  relates to the marketing and selling techniques used by the
          company or an Associated Business or Client (including marketing and
          targeting plans, prospect lists or databases, sales plans, research
          and data surveys);

     (j)  relates to trade secrets, technical specifications, know-how,
          plans, design concepts, ideas, design specifications, manufacturing or
          development processes, research, formulae, processes, applications,
          unique features or techniques in respect of any of the company's or an
          Associated Business' or Clients' products or services, whether
          existing or in development;

     (k)  relates to or is contained in any of the company's or an
          Associated Business' or Clients' computer databases or software;

     (1)  relates to any arrangements or transactions between the company
          or an Associate Business or Client and or its suppliers, contractors,
          employees or consultants (including their identity and the existence
          or size of any fees, prices, commissions or charges paid or payable);

     (m)  all copies of the information, notes and other records referred
          to in paragraph (a) to (1) above,

     except for information that:

     (n)  was rightfully in your possession and not subject to an
          obligation of confidentiality on you before the negotiations leading
          to the commencement of your employment with the company or an
          Associate Business; or

     (o)  is or, after the date of this agreement, becomes available in the
          public domain (other than as a result of a breach of this agreement).

6.   DUTY TO NOT ENDANGER HEALTH AND SAFETY

6.1  The company gives a high priority to health and safety and wilt not
     tolerate smoking in the workplace, or discrimination or harassment of our
     employees. If you are or become a smoker, you will not smoke in or in the
     vicinity of any of our offices or workplaces.

6.2  For the safe and effective operation of the workplace and the welfare of
     other employees, you undertake to abide by, implement and enforce state and
     federal laws and policies of the workplace relating to health and safety,
     discrimination and harassment.

7.   PROGEN POLICIES AND PROCEDURES

7.1  You agree to be bound by all of the company's policies and procedures as
     varied from time to time.

<PAGE>
                                     -5-

8.   TERMINATION

8.1  You may resign, and thereby terminate this agreement, by giving the company
     the appropriate notice of 6 months. If you do not give the required notice
     or payment in lieu, you authorise the company to withhold or deduct from
     any money owed to you, an amount in total or partial satisfaction of that
     obligation.

8.2  The company may dismiss you, and thereby terminate this agreement:

     (a)  without notice if the company has reasonable grounds to suspect
          that you are guilty of Misconduct; or

     (b)  by giving you 6 months notice, or payment of salary in lieu.

8.3  'MISCONDUCT' has its ordinary meaning at law, and includes:

     (a)  any conduct which the company indicate is misconduct or will
          result in summary dismissal;

     (b)  dishonesty or misrepresentation of your expertise,
          qualifications, registration or employment history;

     (c)  not complying with the legislative requirements for a person in
          your position;

     (d)  wilful disobedience of the company's lawful directions;

     (e)  conviction of a criminal offence that affects your suitability
          for your position;

     (f)  drunkenness or intoxication;

     (g)  neglect of duty or incompetence;

     (h)  conduct of a sort which may injure our reputation;

     (i)  engaging in misleading or deceptive conduct or making any
          misrepresentations in relation to the performance of your duties or
          the company's business; or

     (j)  breaching your obligations in paragraphs 2.1 or 5,

9.   POST-TERMINATION ASSISTANCE

9.1  Following termination of your employment, you will, upon request, provide
     the company or an Associated Business with reasonable assistance to the
                                                ----------
     best of your ability in relation to any matter relating directly or
     indirectly to your employment, or which arises out of events which occurred
     during the period of your employment, including providing statements or
     affidavits, attending meetings and attending hearings or inquiries as maybe
     legally required.

9.2  Upon provision of receipts or other documentary evidence to the company's
     satisfaction, the company will reimburse you for any reasonable expenses,
     such as travel and accommodation, incurred by you in providing assistance
     in accordance with section 9.1. The company will also pay you a consultancy
     fee for work undertaken by you in providing that assistance, at an hourly
     rate calculated on the basis of your salary as at termination for a 40 hour
     work week, upon provision of invoices.

<PAGE>
                                     -6-

10.  INTELLECTUAL PROPERTY

10.1 You acknowledge and agree that all existing and future Intellectual
     Property Rights:

     (a)  in any Confidential Information;

     (b)  in respect of any intellectual property developed, in
          development, created or conceived wholly or partly by you, alone or
          together with any other person or body, whether during or outside
          working hours:

          (i)   on the company's or an Associated Business' or Clients'
                premises or using the company's or an Associated Business' or
                Clients' facilities or resources, or facilities or resources
                which were in the care and control of the company or an
                Associated Business or Client or any of our employees, officers,
                agents, sub-contractors or representatives;

          (ii)  directly or indirectly as a result of your or anybody else's
                access to Confidential Information;

          (iii) in the course of, as a consequence of or in relation to the
                performance of your duties; or

          (iv)  relating to the company's or an Associated Business' or
                Clients' general methods of operation; or

     (c)  in respect of or associated with any of the company's or an
          Associated Business' or Clients' products or services, and any
          alterations or additions or methods of making, using, marketing,
          selling or providing those products or services,

     vest in and belong to the company or our nominee to the extent that they
     may for any reason vest in you, are assigned by you to and vest in the
     company or our nominee.

10.2 You agree to execute all documents, including any assignments, and do all
     acts and things, required by the company for the purpose of effecting and
     perfecting the title of the company or the company's nominee to the
     Intellectual Property Rights described in paragraph 10.1, in Australia and
     such other countries as we require.

10.3 You will immediately disclose to the company in writing, any invention or
     improvement you make or of which you conceive during or in the course of
     performing your duties.

10.4 You consent to the company infringing any moral rights that you may have or
     become entitled to in any work created in the course of your employment.
     For the purpose of this consent, 'work' hag the meaning given to that term
     in the Copyright Amendment (Moral Rights) Act 2000 (Cth) and 'moral rights'
     refers to any right arising under the provisions of the legislation,

10.5 'INTELLECTUAL PROPERTY RIGHTS' means any and all beneficial and legal
     ownership and intellectual and industrial protection rights throughout the
     world, both present and future, including rights in respect of or in
     connection with any confidential information, copyright (including future
     copyright and rights in the nature of or analogous to copyright), moral
     rights, inventions (including patents), trade marks, service marks,
     designs, circuit layout and performance protection (whether or not now
     existing and whether or not registered or registrable) and includes any
     right to apply for the registration of such right and all renewals and
     extensions.

<PAGE>
                                     -7-

11.  SECURITY

11.1 You will take all reasonable steps to ensure the security of and protect
     all Confidential Information and intellectual property of the company or
     Associated Business or Client in your possession, power or control.

11.2 You will comply with, and to the best of your endeavours ensure that all
     other employees or contractors engaged by the company or an Associated
     Business comply with, all of the company's or an Associated Business'
     security guidelines, procedures, rules and regulations (whether formal or
     informal).

11.3 If you are provided with any kind of security access device, such as a key
     or computer coded access card, you will:

     (a)  immediately return the device to the company on termination of
          your employment, or earlier request;

     (b)  not copy nor permit the copying of the device or any aspect of it
          which is integral to its function of security;

     (c)  not give the device to anybody else or permit anybody else to use
          the device; and

     (d)  use the device strictly in accordance with any conditions advised
          by the company in respect of it.

11.4 Immediately upon termination of your employment, or upon request at any
     time by the company, you will provide the company with any:

     (a)  Confidential Information;

     (b)  item in respect of which Intellectual Property Rights are held by
          the company or an Associated Business or Client;

     (c)  property, records or information belonging to the company or an
          Associated Business or Client,

     in your possession, power or control, in the form requested by the company
     and to the company's satisfaction.

12.  INTERPRETATION

12.1 All the provisions of this agreement are reasonable in all the
     circumstances and each provision is and shall be deemed to be severable and
     independent and shall not affect the validity or enforceability of any
     other provision.

12.2 This document represents a full record of the company's agreement with
     respect to your employment, and supersedes any prior oral or written
     agreement or understanding between the company and yourself.

12.3 Any award or legislation applicable to your employment does not form part
     of your employment agreement.

12.4 Subject to the company's right to amend policies and manuals and change
     your duties, any amendment to this agreement is not binding unless agreed
     between you and the company and recorded in writing.

<PAGE>
                                     -8-

12.5 This agreement is governed by and is to be construed in accordance with the
     laws of Queensland and the Commonwealth of Australia, You and the company
     submit to the non-exclusive jurisdiction of the courts of Queensland.

12.6 'ASSOCIATED BUSINESS' includes any company, partnership, trust or sole
     trader with common ownership or control (whether in whole or part, directly
     or indirectly, or through interposed entities or not) to the company,
     including any Related Body Corporate (as defined in the Corporations Law)
     to the company.

12.7 'CLIENT' means any persons, company, association or arty other entity to
     whom the company, or any of our Associated Business, provides services,
     advice, products or any other knowledge or know-how during the period of
     your employment.

Please confirm your acceptance of these terms of employment by signing and
returning this letter to me. Yours sincerely,

/s/ Linton Buns
------------------------------
Linton Burns
CFO/Company Secretary
Progen Industries Limited

I accept the offered employment on the terms contained in this letter:

/s/ T. Justus Homburg         Date: 10/06/2006
----------------------
T. Justus Homburg

<PAGE>
                                     -9-

13.  SCHEDULE 1

EMPLOYMENT DETAILS
------------------

<TABLE>
<CAPTION>
-------------------------------------------------------------------------------------------------------
<S>                       <C>
Employer                      PROGEN INDUSTRIES LIMITED
------------------------  -----------------------------------------------------------------------------
Employee's full name          T. JUSTUS HOMBURG
------------------------  -----------------------------------------------------------------------------
Date of Agreement             3 April 2006
------------------------  -----------------------------------------------------------------------------
Date of commencement          1st March 20 06
------------------------  -----------------------------------------------------------------------------
Workplace(1)                  2806 Ipswich Road, Darra, Q4076 and/or
                              16 Benson St. Toowong, Q4066
------------------------  -----------------------------------------------------------------------------
Normal working hours          8:30am - 5:00pm (including lunch)
------------------------  -----------------------------------------------------------------------------
Remuneration              >   Gross salary of $305,200 p.a. inclusive of a base salary of $280,000 and
                              statutory superannuation (9%).

                          >   Short Term Incentive per annum dependent on achievement of strategic
                              and operational objectives set by the Board of up (o 40% of his fixed
                              remuneration.

                          >   Long Term Incentive - A stock options package subject to shareholder
                              approval at the next meeting of shareholders:
                                166,667 - March 1st 2007 at an exercise price equal to a 20% premium
                                to the 60 day share price VWAP prior to this date;
                                166,667 - March 1st 2008 at an exercise price equal to a 25% premium
                                to the 60 day share price VWAP prior to this date;
                                166,667 - March 1st 2009 at an exercise price equal to a 30% premium
                                to the 60 day share price VWAP prior to this date;

                          >   On the provision of proper receipts the company will reimburse you for
                              running expenses for one standard vehicle(2) used by you for work
                              purposes including fuel, insurance and maintenance.
                          -----------------------------------------------------------------------------
Manner of salary payment      Fortnightly in arrears into a bank account nominated by you.
------------------------  -----------------------------------------------------------------------------
Superannuation fund           MLC MasterKey or a superannuation fund nominated by the employee.
------------------------  -----------------------------------------------------------------------------
Leave entitlements            Annual leave, sick leave and long service leave at the minimum levels
                              prescribed by the Industrial Relations Act 1999 (Qld), in accordance with
-------------------------------------------------------------------------------------------------------
</TABLE>

--------------------------------
1 As a condition of this agreement you have agreed that you will Work out of
  Brisbane during the normal working week. You agree to relocate your immediate
  to Brisbane by the end of January 2006.

2 a standard vehicle being a vehicle that costs up to $60,000

<PAGE>
                                      -10-

<TABLE>
<CAPTION>
-------------------------------------------------------------------------------------------------------
<S>                       <C>
                              that Act. Those levels currently are:
                              *   4 weeks' annual leave per completed year of employment(3)
                              *   10 days' sick leave per completed year of employment(4)
                              *   13 weeks' long service leave after 15 years' continuous service, or
                                  pro rate on termination after 10 years' service.
------------------------  -----------------------------------------------------------------------------
Travel/Training           You will be required to reimburse the company, pro-rata any substantial
Reimbursement             training and training related travel costs incurred by the company if you
                          decide to terminate up to 6 months post the event (for costs >$2,000) e.g. if
                          a course costs $5,000 and you decide to leave 3 months after the event, you
                          will be required to repay ($5,000/12) x (12-3) = $3,750 to the company.
------------------------  -----------------------------------------------------------------------------
Other Entitlements        >   Mobile phone for work purposes.
                          >   Memberships to professional societies as agreed to and as needed.
-------------------------------------------------------------------------------------------------------
</TABLE>

--------------------------------------------------------------------------------
(3) To be taken in the year following its accrual pro rata. All leave is subject
to approval and will not be granted where it interferes with significant work
commitments.

(4) Available in circumstances when you are unable to attend work because of
your own incapacity or the need to care for a member of your immediate family.
Paid sick leave will not be available where your absence exceeds 2 days unless a
medical certificate (for you or your family member) is provided. Unused sick
leave may be accumulated from year to year but will not be paid out at
termination.

<PAGE>
                                      -11-

14.  SCHEDULE 2

Position Description
--------------------

<TABLE>
<CAPTION>
-------------------------------------------------------------------
<S>                <C>
Position:          CEO/MANAGING DIRECTOR

Reporting to:      BOARD OF DIRECTORS
Job Description    As described in the CEO job description provided
KPIs               TBA

-------------------------------------------------------------------
</TABLE>

END OF CONTRACT

<PAGE>
                                      -12-

                                                          All Correspondence to:
     PROGEN
INDUSTRIES LIMITED                                           PO Box 2403 Toowong
                                                       Queensland 4066 Australia
Mr T Justus Hamburg                                   Telephone: +61 7 3842 3333
33 Anchorage Street                                   Facsimile: +61 7 3720 9624
CLEVELAND QLD 4163                                             www.progen.com.au

11 September 2006

Dear Justus,

OFFER OF AMENDMENT TO YOUR EMPLOYMENT AGREEMENT

Progen Industries Limited (Progen) proposes to vary the termination Clause of
your current employment agreement with Progen.

If you accept this variation, clause 8.2 of your employment agreement will be
replaced by the following:

     '8.2 The company may dismiss you, and thereby terminate this agreement:
          (a)  without notice if the company has reasonable grounds to
               suspect that you are guilty of Misconduct; or
          (b)  by providing you with notice, or payment of salary in lieu
               of notice, as follows:
               (i)  if another company or entity acquires Control of
                    Progen, for a period of 12 months after the other company or
                    entity acquires - Control - 12 months' notice; or
               (ii) at any other time - 6 months notice.
     'Control' has the meaning given to it in the Corporations Act 2001 (Cth).'

If you accept this variation to your employment agreement, please sign the
enclosed copy of this letter and return it to Linton Burns.

If you would like to discuss the variation, please contact Linton Burns,

Progen would like to take this opportunity to thank you for your continued,
service.

Yours faithfully,

/s/ Linton Burns

Linton Burns
Company Secretary

I accept the amendment to my employment agreement as contained in this letter.

/s/ T. Justus Homburg             11 Sep 2006
---------------------             -----------
T. Justus Homburg                 Date

Corporate Offices and                       Drug Discovery and Biopharmaceutical
Clinical Development                        Manufacturing Facility
16 Benson Street                            2806 Ipswich Road
Toowong QLD 4066                            Darra QLD 4076

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}]]